Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy

Por Navari, Rudolph M
Publicado em 2009

Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)

Por Navari, Rudolph M
Publicado no Drug Des Devel Ther (2014)

Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and Vomiting

Por Navari, Rudolph M.
Publicado no Biomed Res Int (2015)

Safety of Polysorbate 80 in the Oncology Setting

Por Schwartzberg, Lee S., Navari, Rudolph M.
Publicado no Adv Ther (2018)

Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy

Por Navari, Rudolph M., Rapoport, Bernardo L., Powers, Dan, Arora, Sujata, Clark‐Snow, Rebecca
Publicado no Cancer Med (2018)

An accompanying genetic severe deficiency of tissue factor protects mice with a protein C deficiency from lethal endotoxemia

Por Castellino, Francis J., Donahue, Deborah L., Navari, Rudolph M., Ploplis, Victoria A., Walsh, Mark
Publicado em 2011

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

Por Rapoport, Bernardo Leon, Aapro, Matti, Chasen, Martin R, Jordan, Karin, Navari, Rudolph M, Schnadig, Ian, Schwartzberg, Lee
Publicado no Drug Des Devel Ther (2017)

Blood Component Therapy in Trauma Guided with the Utilization of the Perfusionist and Thromboelastography

Por Walsh, Mark, Thomas, Scott G., Howard, Janet C., Evans, Edward, Guyer, Kirk, Medvecz, Andrew, Swearingen, Andrew, Navari, Rudolph M., Ploplis, Victoria, Castellino, Francis J.
Publicado no J Extra Corpor Technol (2011)

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Por Navari, Rudolph M., Qin, Rui, Ruddy, Kathryn J., Liu, Heshan, Powell, Steven F., Bajaj, Madhuri, Dietrich, Leah, Biggs, David, Lafky, Jacqueline M., Loprinzi, Charles L.
Publicado no N Engl J Med (2016)